key: cord-0926563-4r038nah
authors: Hogan, Catherine A.; Gombar, Saurabh; Wang, Hannah; Röltgen, Katharina; Shi, Run-Zhang; Holubar, Marisa; Chang, Sang-ick; Lee, Grace M.; Boyd, Scott D.; Zehnder, James; Pinsky, Benjamin A.
title: Large-Scale Testing of Asymptomatic Healthcare Personnel for Severe Acute Respiratory Syndrome Coronavirus 2
date: 2021-01-03
journal: Emerg Infect Dis
DOI: 10.3201/eid2701.203892
sha: f48e3fa130d5f7efd0d1dd6e38848f0b43f30627
doc_id: 926563
cord_uid: 4r038nah

Large-scale, 1-time testing of >12,000 asymptomatic healthcare personnel in California, USA, during April–June 2020 showed that prevalence of severe acute respiratory syndrome coronavirus 2 was low (<1%). Testing might identify asymptomatic and presymptomatic persons, including some with high viral burden, enabling prompt implementation of measures to limit nosocomial spread.

Large-scale, 1-time testing of >12,000 asymptomatic healthcare personnel in California, USA, during April-June 2020 showed that prevalence of severe acute respiratory syndrome coronavirus 2 was low (<1%). Testing might identify asymptomatic and presymptomatic persons, including some with high viral burden, enabling prompt implementation of measures to limit nosocomial spread. analysis within 2 weeks was recommended to each HCP who had an initial positive rRT-PCR result. HCP were classified as asymptomatic or presymptomatic on the basis of symptoms developing consistent with COVID-19 within 2 weeks after testing.

Statistical analysis was performed by using Stata version 15.1 (https://www.stata.com) and the χ 2 test or Fisher exact test for categorical variables with <5 datapoints/cell and the Mann-Whitney U test for continuous variables. Results were interpreted as significant according to a p value <0.05.

After excluding 12 persons who had a positive rRT-PCR result and earlier illness consistent with COVID-19, we included 12,418 asymptomatic HCP in the study (Figure 1 ). Of these persons, 8,775 (70.7%) were female, and median age was 39.5 years (interquartile range [IQR] 32.4-50.3 years). The SARS-CoV-2 rRT-PCR positivity rate was 26/12,418 (0.2%; 95% CI 0.1%-0.3%), and IgG seropositivity rate was 111/12,373 (0.9%; 95% CI 0.7-1.1). IgG serologic results were not available for 45 persons from the part of the study population for whom only nasopharyngeal rRT-PCR was performed.

Of the 26 persons who had positive rRT-PCR results, 20 remained asymptomatic; for the On the basis of the assumption that these 14 persons (6 presymptomatic and 8 asymptomatic who had early or delayed positive IgG results) had true positive results, the clinical specificity of the test was estimated to be 12,392 (99.9%) of 12,404 (Appendix Table) . The overall median C t was 38.1 (IQR 37.8-38.4) and overlapped between asymptomatic and presymptomatic persons (Appendix Figure) . One asymptomatic HCP had a C t value of 20.8, consistent with high viral load. Testing Healthcare Personnel for SARS-CoV-2

In this cohort of >12,000 asymptomatic HCP from an area that had low COVID-19 in-hospital and community burden at the time of the study, the prevalence of SARS-CoV-2 was low (<1%) by rRT-PCR and IgG serologic analysis. The combined rRT-PCR positivity rate for symptomatic and asymptomatic persons tested during the same period in Santa Clara County was 3.2%, and the county-level proportion of hospitalizations due to COVID-19 was also 3.2% (7) . Other smaller asymptomatic HCP studies have demonstrated positive rRT-PCR prevalence ranging from 1% to 7% (3; E.S. Barrett et al., unpub. data). In addition, point-of-care IgG positivity estimates for asymptomatic persons in studies from Santa Clara and Los Angeles Counties ranged from 1% to 5% (8; E. Bendavid et al., unpub. data). There are limitations in comparability given that rRT-PCR positivity indicates active infection and potentially contagious persons, whereas IgG positivity might indicate past or active infection. However, the findings in the current study suggest that, in low-prevalence settings, HCP SARS-CoV-2 transmission risk might be driven mostly by community exposure, given the limited evidence of nosocomial transmission. In this study, there was no apparent cluster of transmission events from HCP with positive rRT-PCR results. Nonetheless, given that most persons infected with SARS-CoV-2 in this cohort were involved in direct patient care, mass testing that focuses on these persons, as well as implementation in settings lacking personal protective equipment or with a high burden of infection, might show a higher yield (E.S. Barrett et al., unpub. data).

In this study, 1 asymptomatic person was identified who showed high nasopharyngeal viral load, and 6 persons were given a diagnosis before the onset of symptoms. Despite their low frequency, these persons are examples of key groups to identify given the higher likelihood of onward transmission with high viral loads. This study confirmed the overlap in SARS-CoV-2 RNA levels between asymptomatic and presymptomatic HCP, supporting the need for testing both groups to prevent transmission (9) .

There is increasing evidence from congregate settings that relying on the presence of symptoms to initiate testing is insufficient (2, 4) . As laboratory capacity increases, asymptomatic mass testing programs might facilitate earlier and more accurate case detection and help maintain workforce readiness, especially in high-prevalence settings (10) . This testing approach was strengthened by its large scale and comprehensiveness, including tests for viral RNA and SARS-CoV-2 antibodies. Such HCP testing might help build public confidence in the safety of the hospital environment and thus limit delays in care for persons who have non-COVID-19 illnesses.

However, there are limitations to this approach. Previous symptoms were assessed by self-report, which might result in bias. In addition, although the rRT-PCR-positive results in this study could not all be confirmed as true positive results, the estimated clinical specificity of rRT-PCR was 99.9%. Finally, this approach necessitates adequate infrastructure to support intensive clinical triaging, testing, and followup. Sample pooling might increase testing throughput, lower cost, and enable SARS-CoV-2 detection in persons who have high viral load and represent a priority group to prevent transmission.

In summary, large-scale testing of HCP might identify asymptomatic and presymptomatic persons, including some with high viral burden. Early detection might enable prompt implementation of infection control measures to limit nosocomial spread.

of Pathology at Stanford University. Her research interests include novel and point-of-care diagnostics, clinical impact of diagnostic methods, and global health.

Prevalence and clinical presentation of health care workers with symptoms of coronavirus disease

Public Health-Seattle and King County and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility

COVID-19: PCR screening of asymptomatic health-care workers at London hospital

CITIID-NIHR COVID-19 BioResource Collaboration. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

Public Health-Seattle & King County; CDC COVID-19 Investigation Team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility

Comparison of the panther fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2

Open data portal

Seroprevalence of SARS-CoV-2-specific antibodies among adults in

Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea

COVID-19: the case for health-care worker screening to prevent hospital transmission

We thank the members of the Stanford Clinical Virology and Special Chemistry Laboratories for their contributions to testing, and members of the Stanford Occupational Health Center for their work in planning and coordinating this testing effort.